BACKGROUND: Urinary diversion specimens from patients who undergo radical cystectomy are often submitted for urine cytology to screen for recurrent urothelial carcinoma. The objective of the current study was to investigate the frequency and cytohistologic features of cancer recurrence in diversion urine specimens. METHODS: A 10-year retrospective review of archival urinary diversion specimens was conducted. For abnormal cytology cases, cytology slides were reviewed, and their cytomorphology and available corresponding histopathology were documented. RESULTS: In total, 679 diversion urine cytology specimens were identified, of which 39 specimens from 25 patients (5.7 %) had abnormal cytology diagnoses. Seven of 25 patients (28%) had postcystectomy surgical follow-up, and 5 of them manifested with local recurrence.
INTRODUCTION
Urinary bladder cancer accounts for approximately 5% of all new cancers in the United States, where it is the fourth most common cancer and the eighth most common cause of cancer deaths among men. 1 At initial diagnosis, approximately 75% of patients present with nonmuscle-invasive disease, which is usually managed conservatively, whereas approximately 25% of patients present with muscle-invasive disease and often require a cystectomy. 2 Radical cystectomy with pelvic lymph node dissection is the treatment of choice for patients who have muscle-invasive bladder cancer (MIBC) and high-risk non-MIBC, such as: 1) multifocal urothelial carcinoma (UC) in situ (CIS), 2) Bacillus Calmette-Guerin (BCG)-resistant UC, and 3) extensive papillary UC that cannot be managed conservatively. 3 After radical cystectomy, patients are still at risk for local tumor recurrence and disease progression, especially those who have preoperative high-risk features, such as multifocal CIS and prostatic urethral involvement. They are also at risk of developing new UC in their upper urinary tract or retained urethra. Therefore, routine postsurgery surveillance is necessary for early detection and timely treatment of recurrence. Currently, there are no well established guidelines for postcystectomy surveillance. It has been recommended that routine scheduled surveillance should include clinical assessment along with a physical examination, radiologic imaging studies, and urine cytology. 4 There are at least 3 types of diversion urine specimens that a cytology laboratory may receive, including bagged urine in patients with ileal conduits, voided urine in patients with a neobladder, and catheterized urine in patients with continent reservoirs (eg, Indiana pouch). 4 Neobladder specimens allow for simultaneous evaluation of the urothelium of the urethra, ureter, renal pelvis, and anastomotic sites, whereas the other 2 types of specimens cannot be used to monitor the retained urethra. Therefore, urethral washing cytology also typically is indicated in the latter patients. Unlike regular urine specimens, the cytologic features of urine specimens from diversion urine are quite distinct and often challenging. Urinary diversion specimens are usually cellular and comprised of epithelial and inflammatory cells with significant degenerative changes in a background of obscuring gel/lubricant, bacteria, and debris. These features of urinary diversion specimens often impose difficulty in cytopathologic diagnosis related to obscuring material and degenerated cytomorphology.
To date, the performance of diversion urine cytology for the early detection of recurrent or new UC has rarely been studied. 5 Therefore, the current study was designed to determine the frequency of cancer recurrence in diversion urine specimens at our institution and to correlate the cytologic findings with histologic features in patients with abnormal postcystectomy urine cytology diagnoses.
MATERIALS AND METHODS
A retrospective review of our anatomic pathology laboratory information system (Cerner CoPathPlus; Cerner Corporation, Kansas City, Mo) using the keywords "neobladder," "ileal conduit," "Indiana pouch," or "diversion urine" was conducted over a period of 10 years (from January 2006 to January 2016) after approval from our Institutional Review Board. For cases with an abnormal urine cytology diagnosis, we recorded the patients' demographic parameters, cytology diagnoses, presence or absence of subsequent postcystectomy surgical follow-up, and clinical outcomes. Abnormal cytology diagnoses that were included in this analysis were the presence of atypical urothelial cells, suspicious for malignant cells, and positive for malignant cells. For cases with subsequent postcystectomy surgical follow-up, we recorded the patients' demographic details, initial cystectomy histopathology diagnoses with margin status, total number of subsequent diversion urine cytology specimens received, cytologic diagnoses, and histopathology of recurrent tumor, including recurrent tumor location.
All urine samples were fixed in ThinPrep Cytolyt solution and processed to prepare 1 Papanicolaou-stained ThinPrep slide (Hologic Inc, Marlborough, Mass). For abnormal cytology cases, cytology slides were reviewed, and the following cytomorphologic data were gathered: cell clustering or single-cell arrangements of atypical urothelial cells, nuclear features (chromatin, contour, size, and pleomorphism), and cytoplasmic features of abnormal cells, nonurothelial cell types, and background. These data were analyzed using descriptive statistics.
RESULTS
In total, 679 diversion urine cytology specimens were identified. Thirty-nine of these specimens (5.7%) from 25 patients (23 men and 2 women) had an abnormal cytology diagnosis. The average age of these patients was 65 years (range, 54-78 years). Among these 39 specimens, 26 (67%) were diagnosed with atypical urothelial cells, 12 (31%) were suspicious for malignant cells, and 1 (2%) was positive for malignant urothelial cells. In this series, 7 of 25 patients (28%) who had abnormal urine cytology had postcystectomy surgical follow-up. Five of these patients presented with a local recurrence of UC.
Benign Cytologic Findings in Diversion Urine Specimens
The majority of the diversion urine specimens (94.3%) in this study were negative for malignant cells. These specimens contained poorly preserved, degenerated epithelial cells and inflammatory cells present in an obscuring, dirty background. Well preserved, reactive intestinal cells were occasionally present. Unlike atypical urothelial cells, these background cells had low nuclear-to-cytoplasmic (N/C) ratios; vacuolated cytoplasm instead of homogeneous, dense cytoplasm; and exhibited small, degenerated nuclei. Occasional foreign substances were noted, such as gel or lubricant material.
Cytologic Features of Abnormal Diversion Urine Specimens
Diversion urine cytology slides with abnormal diagnoses were retrieved and reviewed. Tables 1 and 2 cytomorphology of diversion urine specimens in patients with suspicious/positive diagnoses and atypical diagnoses, respectively. All of these specimens were hypercellular with mixed cell populations. The atypical urothelial cells were well preserved in contrast to the degenerated background inflammatory and gastrointestinal mucosal cells. The atypical urothelial cells had better preserved, homogeneous, dense cytoplasm that was greenish in color on Papanicolaou-stained ThinPrep slides. Most of the abnormal cases had a single-cell arrangement of these urothelial cells (Fig. 1A) , and occasional samples had rare clusters of atypical urothelial cells (Fig. 1B) . One patient had few papillary clusters of atypical urothelial cells without fibrovascular cores (Fig. 1C) . The atypical urothelial cells had eccentrically located nuclei with high N/C ratios as well as enlarged, hyperchromatic nuclei with irregular nuclear contours. Some cases exhibited coarse or "charcoal" dark chromatin with inconspicuous nucleoli, whereas others exhibited cells with more prominent nucleoli. A cell-incell arrangement was observed in the majority of cases. The recurrent tumor cells exhibited cytomorphologic features similar to those observed in the patients' original positive urine specimens. The background had typical features for diversion urine specimens, being composed of markedly degenerated gastrointestinal mucosal cells, inflammatory cells (mainly neutrophils), bacteria, acellular debris, and mucus. In contrast to the specimens with suspicious/positive diagnoses (Table 1) , the specimens with atypical diagnoses (Table 2) contained sparse atypical cells.
Their cytologic features exhibited wide variation, from mild cytologic atypia to cells with several atypical features observed in suspicious/positive specimens. The corresponding surgical pathology specimens of recurrent tumor demonstrated prominent involvement of the urinary tract tissue adjacent to the site of anastomosis (Fig. 1D ). Table 3 summarizes the pathologic findings of initial cystectomy, diversion urine cytology follow-up findings, as well as histologic features of postcystectomy resection for those patients who had locally recurrent tumors. Five patients demonstrated local recurrence of UC in postcystectomy surgical follow-up specimens. All of these patients were men, and their average age was 69 years (range, 58-78 years). A review of their initial cystectomy specimens revealed that all 5 patients had high-grade UC, including multifocal CIS in 3 of 5 patients, noninvasive carcinoma in 1 of 5 patients, and muscle-invasive carcinoma in 1 of 5 patients. One patient had a margin that was positive for CIS at the time of cystectomy. None of these patients had clinical and/or pathologic evidence of lymph node disease at the time of their initial cystectomy. In follow-up specimens, the pathologic stage rendered on the initial cystectomy specimens was up-graded from CIS to invasive UC in 2 of 5 patients, remained the same in 2 of 5 patients, and 1 patient had CIS only. In addition, hepatic metastasis (n 5 1) and multiple lymph node involvement (n 5 2) Original Article were subsequently noted in 3 of these patients. The site of tumor recurrence was near the site of anastomosis in the distal ureters with involvement of the neobladder/conduit in 3 of 5 patients, at the anastomosis of the urethra with involvement of the neobladder neck in 1 of 5 patients, and in the penile urethra in 1 of 5 patients. Tumor recurrence occurred at an average of 39 months after cystectomy, ranging from 19 to 65 months.
Cytohistologic Correlation in Patients With Tumor Recurrence

Clinical Outcome in Patients With Abnormal Urine Cytology Diagnoses
At the end of the study follow-up, 3 patients had died because of widespread metastasis. One patient remained alive but had a new diagnosis of malignant mesothelioma.
One patient was alive with no evidence of recurrence or progression of his UC. One patient had no malignancy identified after undergoing urethra resection, but he had a perirenal soft tissue fine-needle aspiration biopsy that demonstrated UC. He received neoadjuvant chemotherapy and remained alive. One patient was identified as negative for malignancy; he was closely followed with urine cytology and imaging studies. Eighteen patients did not have postcystectomy surgical follow-up. Among these 18 patients, only 1 had a specimen diagnosed as suspicious/positive for malignant cells. He presented with diffuse right renal pelvis thickening, and the findings were concerning for recurrent UC. The patient underwent Holmium laser resection and received 
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BCG and mitomycin-C but did not undergo surgical resection because of extensive disease and previous left ureteronephrectomy and radical cystectomy. The remaining 17 patients were followed by their urologists routinely without treatment. In this group, tumors recurred at an average of 51 months after cystectomy, ranging from 7 to 180 months.
DISCUSSION
Radical cystectomy with lymph node dissection is the gold-standard of treatment for patients with MIBC and for those with high-risk non-MIBC who are resistant to intravesical treatment. Urothelial tumors can be aggressive in nature. Consequently, the afflicted patients are at risk for local recurrence and distant metastasis. After radical cystectomy, local recurrence rates range from 3.9% to 29%, with the median time to recurrence ranging from 9 to 18 months. 4 In addition, these patients are at risk for recurrence at their retained urethra and upper urinary tract because of the multifocal nature of UC. Approximately 6% to 10% of patients present with tumor recurrence in the retained urethra from 1.5 to 2.2 years after cystectomy, whereas the risk of upper urinary tract recurrence is relative lower (range, 1%-9%) and typically develops after 3 years of disease-free survival. [6] [7] [8] [9] [10] [11] [12] [13] Thus, a scheduled, multidisciplinary, longterm surveillance program that includes urine cytology is warranted for the early detection and timely treatment of recurrent UC tumors. In our series, 5 patients who had abnormal urinary diversion specimens had a tumor recurrence confirmed by histology in postcystectomy surgical follow-up specimens. The time interval for cancer recurrence in these patients ranged from 19 to 65 months, with a mean of 39 months. Four of these patients had a recurrence at an anastomotic site, 1 patient had a penile urethra recurrence, and none of them had an upper tract recurrence. Three of these patients developed more widespread, fatal tumor progression, as evidenced by lymph node involvement and distant metastases. These findings are consistent with previously published data. 4 Urinary diversion urine cytology has been used as a screening test for the detection of recurrent urothelial tumors in patients after radical cystectomy. However, published studies of diversion urine cytology, including the frequency of tumor detection, the performance of this cytology test, cytohistologic correlation, and the cytomorphologic features of recurrent tumor, are sparse. Although some studies demonstrated that urinary cytology could only detect <30% of upper urinary tract recurrences, few studies indicated that urine cytology demonstrated good sensitivity and high specificity. 4, 5, [14] [15] [16] In the current study, we identified 39 abnormal urine cytology specimens from 25 patients over a 10-year period, of which 7 had postcystectomy surgical follow-up. Among those 7 patients, 5 had histologic evidence of local recurrence, 1 had a distant recurrence in perirenal soft tissue, and 1 was free of malignancy. Overall, 5 of 7 patients (71.4%) who had abnormal urine cytology and postcystectomy surgical follow-up in our series had a recurrence on histologic follow-up. Eighteen patients did not have postcystectomy surgical follow-up. Only 1 patient had a specimen diagnosed as suspicious/positive for malignant cells. He presented with evidence of clinical recurrence but did not undergo surgical intervention because of his complicated clinical history. This study was limited, because not all patients who had abnormal urine diagnoses underwent surgical biopsy or resection for tissue confirmation, and some of these patients may have been lost to follow-up. In addition, because not all negative cases were reviewed, we did not investigate the false-negative rate in diversion urinary cytology. In the 5 patients who had histology-proven local tumor recurrences, although they all had abnormal urine cytology diagnoses reported, none had a urine cytology diagnosis that was positive for malignancy. Apart from sampling issues, this also may be related to the reality that the examination of urinary diversion specimens is challenging. These samples all had an obscuring, "dirty" background that hindered accurate cytomorphologic evaluation. They also exhibited sparse, atypical cells among many degenerated inflammatory and gastrointestinal mucosal cells. When present, the recurrent tumor cells were relatively easy to recognize, because they were usually better preserved in contrast to the degenerated background cells. Therefore, whenever well preserved cells with dense, nonvacuolated cytoplasm and hyperchromasia are detected in this setting, cytologists are obligated to investigate the nuclear features of these cells more carefully for possible UC. One caveat is the finding of well preserved intestinal epithelial cells, which have potential to be overdiagnosed as malignant. Intestinal epithelial cells may also present as worrisome, small papillary cell clusters. However, these intestinal cells will have benign nuclear features, such as regular nuclei with smooth contours, fine chromatin, and low N/C ratios. In our series, recurrent tumor cells present in urine diversion samples exhibited cytomorphologic features similar to those observed in the patients' original positive urine specimens. Therefore, comparing a diversion urine specimen that contains atypical cells with a patient's precystectomy urine cytology specimen can be diagnostically helpful.
In conclusion, the data from our institution demonstrate that tumor recurrence in patients who undergo radical cystectomy is rare. Patients with recurrent UC appear to present with aggressive disease, often arising in preexisting urothelium adjacent to the reconstructed neobladder/conduit and with lymph node and/or more distant metastases. Diversion urine cytology is a useful way to monitor these patients for early detection of recurrence. The cytologic interpretation of diversion urine specimens can be challenging because of the low volume of tumor cells present and the obscuring, degenerative cellular background. Therefore, careful and thorough examination of these cytology specimens is warranted.
